Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | EVP & President, SS | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 68,883 |
Reported balance
After 2026-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 5,590 · Balance 68,883 F1: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 20:42 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 5,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000003 · wk-form4_1783370564.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & President, SS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,883 Underlying: Common Stock · 5,590 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. F2 · derivative.expiration_date: All RSUs reported in this row were granted under the Plan and will vest ratably in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 60,865 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 9 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,293 Underlying: Common Stock · 60,865 shares Expires not disclosed F4 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F4 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 16,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 8 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,428 Underlying: Common Stock · 16,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The award was a restricted stock unit award of which 100% vested on the second anniversary of the grant date of 3/11/2024 F3 · derivative.expiration_date: The award was a restricted stock unit award of which 100% vested on the second anniversary of the grant date of 3/11/2024 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 2,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 7 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,994 Underlying: Common Stock · 2,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The award was a restricted stock unit award of which 33% vested on the second anniversary of the grant date of 3/11/2024 F2 · derivative.expiration_date: The award was a restricted stock unit award of which 33% vested on the second anniversary of the grant date of 3/11/2024 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 5,190 | $9.61 | $49,875.90 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 5 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,422 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 18,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 4 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 861 | $9.61 | $8,274.21 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,690 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 1,216 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · derivative · entry 6 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,350 Underlying: Common Stock · 1,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The award was a restricted stock unit award of which 34% vested on the third anniversary of the grant date of 3/10/2023 F1 · derivative.expiration_date: The award was a restricted stock unit award of which 34% vested on the third anniversary of the grant date of 3/10/2023 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 601 | $9.55 | $5,739.55 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,551 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 22:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 1,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-26-000001 · wk-form4_1773353453.xml · nonDerivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 11,965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001949782-25-000003 · wk-form4_1760473706.xml · derivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,566 Underlying: Common Stock · 11,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The award was a restricted stock unit award which vested in full on the third anniversary of the grant date of 10/12/2022. F2 · derivative.expiration_date: The award was a restricted stock unit award which vested in full on the third anniversary of the grant date of 10/12/2022. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 3,281 | $13.34 | $43,768.54 |
DisclosureSEC source: 0001949782-25-000003 · wk-form4_1760473706.xml · nonDerivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,936 F1 · shares: Represents shares withheld to satisfy the reporting person's tax withholding obligation with respect to 11,965 shares of common stock issued upon the vesting of time based restricted stock units on October 12, 2025. The reporting person retained the remaining 8,684 shares. Read SEC document |
| October 12, 2025 Filed Oct 14, 2025 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 11,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001949782-25-000003 · wk-form4_1760473706.xml · nonDerivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 20,133 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0000917520-25-000023 · wk-form4_1741897468.xml · derivative · entry 5 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,133 Underlying: Non-Qualified Stock Option (right to buy) · 20,133 shares Expires 2033-03-11 F2 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2025. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 2,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000023 · wk-form4_1741897468.xml · derivative · entry 4 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,531 Underlying: Common Stock · 2,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2024. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2024. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 9,508 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000023 · wk-form4_1741897468.xml · nonDerivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,252 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 647 | $23.95 | $15,495.65 |
DisclosureSEC source: 0000917520-25-000023 · wk-form4_1741897468.xml · nonDerivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,744 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 2,356 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000023 · wk-form4_1741897468.xml · nonDerivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 1,180 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000018 · wk-form4_1741724159.xml · derivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,887 Underlying: Common Stock · 1,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 324 | $22.61 | $7,325.64 |
DisclosureSEC source: 0000917520-25-000018 · wk-form4_1741724159.xml · nonDerivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,035 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 1,180 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000018 · wk-form4_1741724159.xml · nonDerivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 16,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000031 · wk-form4_1710361560.xml · derivative · entry 3 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,067 Underlying: Common Stock · 16,566 shares Expires not disclosed F3 · derivative.exercise_price: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 3/11/2024. F3 · derivative.exercise_date: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 3/11/2024. F3 · derivative.expiration_date: The award was a restricted stock unit award which will vest 100% on the second anniversary of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 7,140 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000031 · wk-form4_1710361560.xml · derivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,501 Underlying: Common Stock · 7,140 shares Expires not disclosed F2 · derivative.exercise_price: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2024. F2 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2024. F2 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 16,493 | $0.00 Strike: $36.22 | $0.00 |
DisclosureSEC source: 0000917520-24-000031 · wk-form4_1710361560.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,493 Underlying: Common Stock · 16,493 shares Expires 2032-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024. Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionRestricted Stock Units · Derivative | 1,179 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000024 · wk-form4_1710277801.xml · derivative · entry 2 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,361 Underlying: Common Stock · 1,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F2 · balance_after: Includes adjustment to correct a de minimis error on a previously filed Form 4 of the reporting person which had resulted in the over-reporting of restricted stock units ("RSUs") beneficially-owned by the reporting person by ninety-five RSUs. Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 1,179 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000024 · wk-form4_1710277801.xml · nonDerivative · entry 1 Singh Harvinder · CIK 0001949782 · EVP & PRESIDENT, INTERNATIONAL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 3,670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018441 · doc4.xml · derivative · entry 2 Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,635 Underlying: Common Stock · 3,670 shares Expires not disclosed F2 · derivative.exercise_price: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F2 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F2 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,990 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018441 · doc4.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,990 Underlying: Common Stock · 8,990 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| October 12, 2022 Filed Oct 13, 2022 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 11,965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053568 · doc4.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,965 Underlying: Common Stock · 11,965 shares Expires not disclosed F1 · derivative.exercise_price: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022 F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022 F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.